Clinical trial
National Registry of Rare Kidney Diseases (RaDaR)
NCT06065852 is registered in ClinicalTrials.gov with UK Kidney Association as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- National Registry of Rare Kidney Diseases (RaDaR)
- Lead sponsor
- UK Kidney Association
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 6, 2009
- Completion date
- December 31, 2039
- Enrollment
- 35,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenine phosphoribosyltransferase deficiency, ah amyloidosis, ahl amyloidosis, al amyloidosis, alport syndrome, atypical hemolytic uremic syndrome, autoimmune distal renal tubular acidosis, autosomal dominant polycystic kidney disease, autosomal recessive distal renal tubular acidosis, autosomal recessive polycystic kidney disease, autosomal recessive proximal renal tubular acidosis, bartter syndrome, bk nephropathy, c3 glomerulopathy, c3 glomerulopathy with monoclonal gammopathy, calciphylaxis, crystal-storing histiocytosis, crystalglobulinaemia, cystinosis, cystinuria, dense deposit disease, dent disease, denys-drash syndrome, dominant hypophosphataemia with nephrolithiasis and/or osteoporosis, drug induced fanconi syndrome, drug-induced hypomagnesemia, drug-induced nephrogenic diabetes insipidus, epilepsy, ataxia, sensorineural deafness and tubulopathy, fabry disease, familial hypomagnesemia with hypercalciuria and nephrocalcinosis, familial primary hypomagnesaemia with normocalciuria, familial primary hypomagnesemia with hypocalcuria, familial renal glucosuria, fanconi renotubular syndrome 1, fanconi renotubular syndrome 2, fanconi renotubular syndrome 3, fibrillary glomerulonephritis, fibromuscular dysplasia, focal segmental glomerulosclerosis, generalised pseudohypoaldosteronism type 1, gitelman syndrome, heavy-metal-induced fanconi syndrome, hepatocyte nuclear factor 1-beta-associated monogenic diabetes, hereditary hypophosphatemic rickets with hypercalciuria, hereditary renal hypouricemia, hyperuricaemic nephropathy, iga nephropathy, immunotactoid glomerulonephritis with organised microtubular mononoclonal immunoglobulin deposits, inherited renal cancer syndromes, intracapillary monoclonal igm without cryoglobulin, intraglomerular/capillary lymphoma/leukaemia, isolated autosomal dominant hypomagnesaemia glaudemans type, liddle syndrome, light chain cast nephropathy, light chain proximal tubulopathy with crystals, light chain proximal tubulopathy without crystals, lowe syndrome, medullary cystic kidney disease, membranoproliferative glomerulonephritis, membranous nephropathy, minimal change nephropathy, mitochondrial disease of the kidney, monoclonal immunoglobulin deposition disease, nail patella syndrome, nephrogenic diabetes insipidus, nephrogenic syndrome of inappropriate antidiuresis, nephronophthisis, primary hyperoxaluria, primary hypomagnesemia with secondary hypocalcemia, proliferative glomerulonephritis with monoclonal igg deposits, proximal tubulopathy without crystals, pseudohypoaldosteronism type 1, 2a-2e, pure red cell aplasia, retroperitoneal fibrosis, shiga toxin associated haemolytic uraemic syndrome, sickle cell nephropathy, steroid resistant nephrotic syndrome, steroid-sensitive nephrotic syndrome, thin basement membrane nephropathy, thrombotic microangiopathy with monoclonal gammopathy, tuberous sclerosis, type 1 cryoglobulinaemic glomerulonephritis, unclassified monoclonal gammopathy of renal significance, vasculitis